Fill Out Form to Receive Your Free Myeloma Information Pamphlet

March is Myeloma Awareness Month

Infographic: What is Multiple Myeloma?

march is myeloma awareness month infographic

ABOUT BINDING SITE

Binding Site is the manufacturer of the sole U.S. Food and Drug Administration-approved Freelite serum free light chain assay. Freelite is more sensitive than electrophoretic methods for detecting multiple myeloma and AL amyloidosis patients who often first present with renal failure. The NCCN Guidelines and the International Myeloma Working Group recommend the use of Freelite in the initial diagnostic workup of multiple myeloma and related disorders.1  

1. Referenced with permission from The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Multiple Myeloma V.1.2015. © National Comprehensive Cancer Network, Inc. 2014. All rights reserved. Accessed February 18, 2015. To view the most recent and complete version of the guideline, go online to www.nccn.org.  NATIONAL COMPREHENSIVE CANCER NETWORK®, NCCN®, NCCN GUIDELINES®, and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc.